Efficacy and safety of a 3rd dose of mRNA-1273 SARS-CoV-2 vaccine

By | May 5, 2022
In a recent study posted to the Research Square* preprint server, researchers tested the safety and immunogenicity of a third dose of coronavirus disease 2019 (COVID-19) prototype messenger ribonucleic acid (mRNA)-1273 versus a variant vaccine and a bivalent vaccine formulation.